Advanced Oncotherapy (AVO)


Latest News

AVO - Progress at Harley Street, timelapse

Advanced Oncotherapy operating losses widen

Advanced Oncotherapy's operating losses rose to 7.3m in the six months to the end of June - up from 5.9m last time. Revenu...

Half-year Report

RNS Number: 1735S Advanced Oncotherapy PLC 29 September 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Half-year Report Advanced Oncotherapy (AIM: AVO), the developer of a next generation proton therapy system for cancer treatment, announces its unaudited results for the six months ended 30 June 2017 and po...

Advanced Oncotherapy - Technological update

All News

23-10-17AVO - Progress at Harley Street, timelapseBRR Media
29-09-17Advanced Oncotherapy operating losses widen StockMarketWire
29-09-17Half-year ReportRNS
05-09-17Advanced Oncotherapy - Technological updateBRR Media
04-09-17Technological updateRNS
03-08-17Advance Oncotherapy - Interview with Gabriel UrwitzBRR Media
01-08-17Director Deals - Advanced Oncotherapy PLC (AVO)StockMarketWire
01-08-17Director DealingRNS
31-07-17Technological milestones update - CCL unitsRNS
19-07-17Result of AGMRNS
19-07-17Financing facility by significant shareholdersRNS
05-07-17Video and update on progress at Harley StreetRNS
05-07-17Advanced Oncotherapy - Harley Street update with Deconstruct UKBRR Media
26-06-17Final ResultsRNS
21-06-17Conversion of Convertible Loan NotesRNS
14-06-17Advanced Oncotherapy appoints senior VP of medical physics StockMarketWire
14-06-17Appointment of Senior VP of Medical PhysicsRNS
13-06-17Additional financing agreement and new appointmentRNS
12-06-17Advanced Oncotherapy update on milestones StockMarketWire
12-06-17Technological milestones updateRNS
05-06-17Update on Bracknor financingRNS
31-05-17Holding(s) in CompanyRNS
30-05-17Harley Street construction updateRNS
26-05-17Conversion of Convertible Loan NotesRNS
26-05-17Advanced Oncotherapy draws down £1.3mStockMarketWire
26-05-17Update on Bracknor financingRNS
24-05-17Conversion of convertible loan notesRNS
23-05-17Holding(s) in CompanyRNS
18-05-17Conversion of convertible loan notesRNS
16-05-17Conversion of loan notesRNS
15-05-17Director Deals - Advanced Oncotherapy PLC (AVO)StockMarketWire
15-05-17Director DealingRNS
11-05-17Director Deals - Advanced Oncotherapy PLC (AVO)StockMarketWire
11-05-17Director DealingRNS
08-05-17Issue of Equity & Director ShareholdingRNS
04-05-17Holding(s) in CompanyRNS
03-05-17Holding(s) in CompanyRNS
28-04-17Advanced Oncotherapy draws down £1.3mStockMarketWire
28-04-17Update on Bracknor financingRNS
26-04-17Director Deals - Advanced Oncotherapy PLC (AVO)StockMarketWire

RSS feeds

  • Editorial news feed for LSE:AVO Editorial
  • Regulatory news feed for LSE:AVO Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account